Cargando…

Anti‐A/B isoagglutinin reduction in an intravenous immunoglobulin product and risk of hemolytic anemia: a hospital‐based cohort study

BACKGROUND: Intravenous immunoglobulins (IVIG) are derived from large human plasma pools. IVIG‐associated hemolytic anemia (HA) is a known class effect, likely attributed to dose‐dependent passive transfer of anti‐A/B isoagglutinins. Two isoagglutinin reduction steps were implemented in the manufact...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wallenhorst, Christopher, Patel, Ami, Shebl, Amgad, Hubsch, Alphonse, Simon, Toby L., Martinez, Carlos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2020
Materias:	Transfusion Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7496198/ https://www.ncbi.nlm.nih.gov/pubmed/32488887 http://dx.doi.org/10.1111/trf.15859

Ejemplares similares

Impact of screening and exclusion of high anti‐A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment: A hospital‐based cohort study in the US
por: Martinez, Carlos, et al.
Publicado: (2017)

Isoagglutinin reduction in intravenous immunoglobulin (IgPro10, Privigen) by specific immunoaffinity chromatography reduces its reporting rates of hemolytic reactions: an analysis of spontaneous adverse event reports
por: Shebl, Amgad, et al.
Publicado: (2020)

Reduction of Isoagglutinin in Intravenous Immunoglobulin (IVIG) Using Blood Group A- and B-Specific Immunoaffinity Chromatography: Industry-Scale Assessment
por: Gerber, Simon, et al.
Publicado: (2016)

Isoagglutinin Reduction in Human Immunoglobulin Products by Donor Screening
por: Siani, Brigitte, et al.
Publicado: (2014)

Incidence and risk factors for intravenous immunoglobulin‐related hemolysis: A systematic review of clinical trial and real‐world populations
por: Cuesta, Hillary, et al.
Publicado: (2022)

Intravenous Immunoglobulin-Associated Severe Hemolytic Anemia
por: KC, Ojbindra, et al.
Publicado: (2023)

Reduction of anti‐K‐mediated hemolytic disease of newborns after the introduction of a matched transfusion policy: A nation‐wide policy change evaluation study in the Netherlands
por: Luken, Jessie S., et al.
Publicado: (2021)

Murine models of autoimmune hemolytic anemia
por: Howie, Heather L., et al.
Publicado: (2018)

Warm autoimmune hemolytic anemia: new insights and hypotheses
por: Branch, Donald R.
Publicado: (2023)

Antibody profiles in COVID‐19 convalescent plasma prepared with amotosalen/UVA pathogen reduction treatment
por: Bagri, Anil, et al.
Publicado: (2022)

Neonatal sepsis in alloimmune hemolytic disease of the fetus and newborn: A retrospective cohort study of 260 neonates
por: Jansen, Sophie J., et al.
Publicado: (2022)

Low anti-RhD IgG-Fc-fucosylation in pregnancy: a new variable predicting severity in haemolytic disease of the fetus and newborn
por: Kapur, Rick, et al.
Publicado: (2014)

Successful ABO-incompatible living donor liver transplantation using splenectomy and intravenous immunoglobulin in high isoagglutinin titer patients
por: Lee, Boram, et al.
Publicado: (2020)

Isoagglutinin‐reduced immunoglobulin retains efficacy in mouse models of immune thrombocytopenia and rheumatoid arthritis and is less likely to cause intravenous immunoglobulin–associated hemolysis
por: Cen, Selena Y., et al.
Publicado: (2019)

Racial differences in red blood cell transfusion in hospitalized patients with anemia
por: Prochaska, Micah, et al.
Publicado: (2022)

APPEARANCE OF ISOAGGLUTININS IN INFANTS AND CHILDREN
por: Happ, W. M.
Publicado: (1920)

Predicting organ functioning with and without blood transfusion in critically ill patients with anemia
por: Kranenburg, Floris J., et al.
Publicado: (2022)

Hemolytic anemia following intravenous immunoglobulins in children with PIMS-TS: Two case reports
por: Sedlin, E., et al.
Publicado: (2023)

Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study
por: Martinez-Saguer, Inmaculada, et al.
Publicado: (2014)

Association between maternal haemoglobin and stillbirth: a cohort study among a multi‐ethnic population in England
por: Nair, Manisha, et al.
Publicado: (2017)

Amustaline‐glutathione pathogen‐reduced red blood cell concentrates for transfusion‐dependent thalassaemia
por: Aydinok, Yesim, et al.
Publicado: (2019)

Blood utilisation and transfusion reactions in adult patients transfused with conventional or pathogen‐reduced platelets
por: Bahar, Burak, et al.
Publicado: (2019)

The effect of extended c, E and K matching in females under 45 years of age on the incidence of transfusion‐induced red blood cell alloimmunisation
por: Oud, Josine A., et al.
Publicado: (2021)

International guidelines regarding the role of IVIG in the management of Rh‐ and ABO‐mediated haemolytic disease of the newborn
por: Lieberman, Lani, et al.
Publicado: (2022)

Individual Variation in Growth Factor Concentrations in Platelet-rich Plasma and Its Influence on Human Mesenchymal Stem Cells
por: Cho, Hee Soon, et al.
Publicado: (2011)

Establishing a perinatal red blood cell transfusion risk evaluation model for obstetric patients: a retrospective cohort study
por: Xing, Zhun, et al.
Publicado: (2019)

COVID-19 and the Coombs test
por: Hendrickson, Jeanne E., et al.
Publicado: (2020)

Washing or filtering of blood products does not improve outcome in a rat model of trauma and multiple transfusion
por: Wirtz, Mathijs R., et al.
Publicado: (2018)

The assessment of platelet function by thromboelastometry as a point‐of‐care test to guide Intercept‐treated platelet support in hemato‐oncological patients and hematopoietic stem cell transplantation recipients
por: Leitner, Gerda C., et al.
Publicado: (2020)

Transfusion of pathogen‐reduced platelet components without leukoreduction
por: Sim, Joycelyn, et al.
Publicado: (2019)

Clinical impact of amotosalen‐ultraviolet A pathogen‐inactivated platelets stored for up to 7 days
por: Infanti, Laura, et al.
Publicado: (2019)

Does the evidence support the importance of high transfusion ratios of plasma and platelets to red blood cells in improving outcomes in severely injured patients: a systematic review and meta‐analyses
por: da Luz, Luis Teodoro, et al.
Publicado: (2019)

Missed irradiation of cellular blood components for vulnerable patients: Insights from 10 years of SHOT data
por: Elliot, Johnathon, et al.
Publicado: (2020)

Expected individual benefit of prophylactic platelet transfusions in hemato‐oncology patients based on bleeding risks
por: Cornelissen, Loes L., et al.
Publicado: (2021)

Chewing the fat on TRALI
por: Cleary, Simon J., et al.
Publicado: (2021)

Convalescent plasma treatment of critically ill intensive care COVID‐19 patients
por: Lindemann, Monika, et al.
Publicado: (2021)

Impact of the preparation method of red cell concentrates on transfusion indices in thalassemia patients: A randomized crossover clinical trial
por: Gamberini, Maria Rita, et al.
Publicado: (2021)

Association between renal failure and red blood cell alloimmunization among newly transfused patients
por: Oud, Josine A., et al.
Publicado: (2020)

Measures to reduce red cell use in patients with sickle cell disease requiring red cell exchange during a blood shortage
por: Uter, Stacey, et al.
Publicado: (2021)

Transfusion of target antigens to preimmunized recipients: a new mechanism in transfusion-related acute lung injury
por: Bayat, Behnaz, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_db38fsjgp7cc3dnu942qrkev9h